Our Company

Ergomed Group Sites

Technology-driven Solutions

Optimise your PV operations through monitoring and use of technology by our SMEs.

Come to rescue of your PV systems during service provider modifications or technology switch.

Help our long-standing clients to develop in-house pharmacovigilance capacity.

Streamline your PV systems and processes during expansion.

Strengthen your negotiations with regulators, HTAs and external stakeholders.

Product Expertise

Pharmacovigilance expertise to support the development of risk minimisation measures pre-, peri- and post-marketing, complex ICSR management and an evaluation strategy of Innovative/Brand portfolio.

Methodical management of challenging pharmacovigilance agreements (SDEAs), signal detection, audits schedules & conduct and training for Generics, Hybrids and Biosimilars.

A comprehensive pharmacovigilance management of seasonal Vaccines ICSRs and systems, well-positioned to coordinate end-to-end PV activities of your immunisation portfolio.

Our vigilance and pharmacovigilance experts can advise you on the complex regulatory prerequisites that characterise PV activities related to medical devices and combination products.

We never underestimate the importance of performing tailored PV research in pediatrics and draw lessons from risk minimisation of ARs in adult population.

We adjust or co-develop your risk management plans cognizant that co-morbidities or side effects, which are specific to older patients, may shape your post-authorisation PV activities.